Wet AMD: What You Need to Know About Treatment and Vision Protection

One of the earliest and most common signs of wet AMD is called metamorphopsia, which means straight lines appear wavy, bent, or broken. Door frames, window blinds, and lines of text may look curved or irregular. This distortion can develop over hours to days and often affects one eye before the other.

If straight lines that looked normal yesterday appear wavy today, contact an eye doctor the same day. This symptom often indicates that fluid is accumulating beneath your macula and active leakage may be occurring.

A scotoma, which is a blind or blurry spot in your central vision, may appear as a dark, gray, or blank area. You may notice it most when reading, recognizing faces, or looking at a screen. The appearance of this spot can vary depending on whether fluid or blood is responsible.

This spot can grow if treatment is delayed. Any new blank area in your central vision requires urgent evaluation from an eye doctor.

Wet AMD often begins in one eye before affecting the other. If one eye becomes noticeably worse over a period of days, try covering your stronger eye and checking whether the weaker eye shows new blur, distortion, or blank patches.

Rapid vision decline in one eye is not a normal part of aging. It signals active fluid leakage beneath the retina, and treatment started within days of symptom onset tends to produce better outcomes than treatment delayed by weeks.

There is currently no treatment that eliminates wet AMD entirely. Anti-VEGF injections control the disease by suppressing abnormal blood vessel activity and reducing fluid, but they do not reverse the underlying condition. Most patients need ongoing treatment for the rest of their lives to keep the disease stable and protect their remaining vision.

The eye is numbed thoroughly with anesthetic drops before the injection, so most patients feel only a brief sense of pressure rather than sharp pain. The injection itself takes just a few seconds. Mild soreness or a gritty feeling may follow for a day or so, but this typically resolves on its own. Most patients are surprised by how manageable the experience is after their first injection.

The most common side effects are mild and temporary, including redness at the injection site, brief floaters, and minor irritation. Serious complications such as infection inside the eye or retinal detachment are rare. Your eye doctor uses careful sterile technique to minimize these risks. If you notice significant pain, increasing redness, or sudden vision changes after an injection, contact your eye doctor promptly rather than waiting for your next scheduled visit.

Most patients return to normal daily activities within a day of their injection. Air travel is generally considered safe. Your eye doctor will give you specific aftercare instructions, which typically include avoiding rubbing your eye for the first 24 hours. If you have questions about strenuous exercise or specific physical activities, ask your eye doctor directly, as individual circumstances can vary.

If your retina continues to show fluid despite consistent treatment with one anti-VEGF drug, your eye doctor may switch to a different agent. Patients sometimes respond better to one medication than another, and switching is a well-established strategy. Regular OCT monitoring at each visit allows your eye doctor to detect a reduced response early and adjust your plan before significant damage occurs.

Researchers are investigating single-dose gene therapies designed to allow your eye to produce its own anti-VEGF protein, which could reduce or eliminate the need for ongoing injections. As of 2026, gene therapy for wet AMD remains under clinical investigation and is not yet an approved standard treatment. Your eye doctor can discuss emerging options and whether any trials may be appropriate for your situation.